Axmed raises $2M from Founderful to streamline drug supply chains in underserved markets
- About 2 billion people lack access to quality and affordable essential medicines.
- Axmed raised $2 million in seed funding from Founderful Ventures.
- Axmed aims to fix supply chain fragmentation and connect manufacturers with health institutions to reduce shortages and the proliferation of counterfeit drugs.
Axmed's mission to address the lack of access to essential medicines in lower and middle-income countries is commendable. By fixing supply chain fragmentation and connecting manufacturers with health institutions, they can reduce shortages and the prevalence of counterfeit drugs. The platform's focus on empowering buyers and patients while creating an attractive market for high-quality manufacturers is a step in the right direction.
